Jasper Therapeutics(JSPR) - 2021 Q2 - Quarterly Report

For the quarterly period ended June 30, 2021 Commission File Number: 001-39138 AMPLITUDE HEALTHCARE ACQUISITION CORPORATION OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _______ to _______ (Exact name of registrant as specified in its charter) | Dela ...